Intervet
Encephalomyelitis-Rhinopneumonitis-Influenza Vaccine
Eastern and Western, Killed Virus
Tetanus Toxoid
A combination of inactivated, purified, concentrated, adjuvanted, tissue culture origin Equine Encephalomyelitis Virus, Eastern and Western, Equine Herpesvirus EHV-1 and EHV-4, Equine Influenza Virus subtypes A1 and A2 including KY93 strain, and Tetanus Toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Prague 56, Detroit 91, Miami 63, Kentucky 93, 94, 95, 96, Suffolk 89, Kildare 89 and 92, Austria 92, Switzerland 93, New Market/1/93, and /2/93, Berlin 94, Italy 96 and Meath 96.**
Indications: For vaccination of healthy horses against Eastern and Western Encephalomyelitis, Equine Influenza Virus and Tetanus, and as an aid in the prevention of respiratory disease caused by Equine Herpesvirus and Equine Influenza Virus.
Dose: For primary immunization aseptically inject 1 mL intramuscularly and repeat the dose in 3 to 4 weeks. A 1 mL dose should be administered annually and at any time epidemic conditions exist or are reported and exposure is imminent.
Caution: Store at 35° to 45°F (2° to 7°C). Shake well before using. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Local reactions may occur if this product is given subcutaneously. Inject deep into the muscle only. Anaphylactoid reactions may occur.
Antidote: Epinephrine.
Neomycin, polymyxin B, nystatin and thimerosal added as preservatives.
*Adjuvant - Intervet's Proprietary Technology
**Data available upon request.
FOR USE IN ANIMALS ONLY
Intervet, Inc.
405 State St., P.O. Box 318, Millsboro, DE 19966
1-800-441-8272
www.intervet-usa.com
Disclaimer
Every effort has been made by Stockyards to ensure the accuracy of the information listed above. However, it remains your responsibility to become familiar with the products you are purchasing. Please consult your family veterinarian if you have any questions.
